Companies in #Thyroid Eye Disease

Sling Therapeutics is a clinical-stage biopharmaceutical company in Ann Arbor, Michigan developing linsitinib, the first and only late-stage oral small-molecule IGF-1R inhibitor for the treatment of thyroid eye disease (TED).

Viridian Therapeutics is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for autoimmune diseases and rare conditions, with a focus on FcRn inhibitors and thyroid eye disease.

Clinical-stage biotech developing monoclonal antibody therapies for autoimmune thyroid diseases (Graves' disease, thyroid eye disease). Lead candidate YB-101 targets TSHR receptor.